Navigation Links
QPS Expands Clinical Trial Services with Acquisition of Qualitix

NEWARK, Del. and TAIPEI, Taiwan, March 8, 2011 /PRNewswire/ -- QPS, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the acquisition of a majority interest of Qualitix Clinical Research. Qualitix, a spin-off of the biotechnology company Genovate, Inc, is a full service CRO with offices in Taiwan and China. Genovate will retain a minority interest in Qualitix, which will be known as QPS-Qualitix Taiwan.

QPS is a global CRO supporting drug discovery and development since 1995. Its six areas of expertise include: Toxicology, DMPK, Bioanalytical, Translational Medicine, Early Stage Clinical and Late Stage Clinical Research.

Qualitix is a Contract Research Organization and Site Management Organization offering high quality, cost effective research development services to assist clients in pharmaceutical, biotechnology and medical device industries engaged in new drug development and phase I-IV multinational clinical trials.

QPS-Qualitix will have the broadest range of product development, clinical research, and regulatory services in Taiwan. With its strong Asia-Pacific regional network of CRO partners, QPS-Qualitix acts as an attractive launching point from which clients may address the rapidly growing Asian market. QPS-Qualitix also owns a subsidiary corporation called Unitix – a site management organization which affords QPS-Qualitix the unique advantage of speedy patient recruitment in the region.

State-of-the-art clinical trial management and electronic data capture systems enable QPS-Qualitix to deliver first rate data management and biostatistics services, which will complement the same streamlined clinical information capabilities offered by QPS Netherlands and QPS-Bioserve India.

"We are very happy to partner with QPS. This partnership will not only allow Qualitix to vertically integrate with QPS for more global exposure and market competitiveness, but also offer complete services from preclinical to clinical to expedite new drug development," says Dr. Jen Chen, CEO of Genovate.

"This expansion in Phase I-IV clinical capability dovetails with our recent preclinical facility acquisition here in Taiwan," says Vincent Yen, President and CEO of QPS-Taiwan. "This represents the fourth cross-border acquisition QPS has made in the last six months. Clients all over the world will now have access to an even wider range of the exceptional services they have come to expect from QPS, along with an expanding global footprint."

QPS-Qualitix has an established network of prominent Taiwanese investigators at all 22 medical centers. It is the largest local CRO with broad clinical trial expertise, handling IND trials mainly focused on oncology and metabolic disorders in Taiwan, for global filing. The depth and breadth of QPS-Qualitix's experience in this important therapeutic field attracts major clients and partners including global pharmaceutical clients as well as local pharmaceutical and biotech clients from the Asia-Pacific region.

About QPS

QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide in the areas of Bioanalysis, Drug Metabolism and Pharmacokinetics, Toxicology, Translational Medicine, and Clinical Research. Founded by Dr. Ben Chien in 1995, QPS has Bioanalysis and Preclinical testing facilities at its Newark, DE headquarters; and facilities in Groningen, the Netherlands; Taipei, Taiwan; and Hyderabad, India. Early-phase clinical facilities are located in Springfield, MO; Taipei, Taiwan; Groningen, the Netherlands; and Hyderabad, India. Business development offices are maintained in the US, Europe, and Asia.

About Qualitix

Qualitix is a full service CRO based in Taipei, Taiwan and Shanghai, China, and focuses on clinical monitoring and site management services for multinational clinical trials. Its major clients and partners are international pharmaceutical and biotechnology industries. At Qualitix, well-trained Clinical Research Associates, Project Managers, Regulatory Affairs Staff, Quality Control Staff, Safety Reporters and Clinical Research Trainers produce high-quality studies with high patient enrollment rates. Major therapeutic categories covered are Infectious Disease, Cardiovascular Disease, Gastroenterology, Asthma/COPD, Immunology, Obstetrics and Gynecology, Oncology and CNS

About Genovate

Genovate Biotechnology Co., Ltd. is a fully integrated biopharmaceutical company located in Taiwan, that is committed to develop innovative medicinal products that can improve people's health and quality of life. Founded in 1995 as an alliance comprised of industry, government, and private investors, Genovate currently employs a total of approximately 120 people who develop a balanced product portfolio of proprietary drugs for a number of therapeutic indications such as lupus, oncology, urinary incontinence and Type 2 diabetes. Genovate also promotes and sells a range of pharmaceutical (niche) products from foreign pharmaceutical companies through a network of local agents in Taiwan as well as in other parts of the Asia Pacific Region.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Linden Care, ... and optimizing treatment outcomes for patients suffering from chronic ... request for a Temporary Restraining Order (TRO) enjoining Express ... the two companies. --> ... pursuing all of its legal options. ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology:
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... Secura Consultants has prided itself for not only fulfilling the needs of advisers ... solutions at an affordable price and providing top-tier customer service. However, there's always ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa Rosa ... Sepsis conditions present in similar ways and require time-critical intervention to avoid large area ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... ... ... Jobs in hospital medical laboratories and in the imaging field lead the many ... Medical Group . These fields, as well as travel nursing, ranked at ... through the company’s website, , The leading healthcare staffing agency released ...
Breaking Medicine News(10 mins):